Accelerating progress from advanced to early breast Cancer

by H. Rugo
Published 2021-04-01

Safety outcomes from monarchE: Phase 3 study of abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER-2-, node-positive, high risk, early breast cancer

by H. Rugo, J. O’Shaughnessy, C. Song, R. Broom, M. Gumus, T. Yamashita, B. San Antonio, A. Shahir, A. Zimmermann, F. Zagouri, M. Reinisch
Published 2021-04-01